Carl Friddle Email & Phone Number

Built an MSL team in the US to support the development and launch of BioCryst's novel compound targeting plasma Kallikrein.

Houston, Texas Area

I led a group of 6 Medical Science Liaisons for Therakos Extracorporeal Photopheresis across North America.Therakos supports clinicians by providing high quality products and world class training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for GvHD and autologous immune cell therapy. In Canada we are approved for Systemic Sclerosis (Scleroderma). We engage dermatologists, oncologists, rheumatologists and transplant physicians. I was previously a Regional Director for INOMAX (inhaled nitric oxide) and I continue to support INOMAX in Canada.

Houston

I led a team of MSLs in pulmonary critical care with clinical research in neuroscience. INOMAX (inhaled nitric oxide) is a vasodilator, which, in conjunction with ventilatory support and other appropriate agents, is indicated for the treatment of term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, where it improves oxygenation and reduces the need for extracorporeal membrane oxygenation.INOMAX delivery systems are compatible with more than 50 models of ventilators and anesthesia machines.

Houston, Texas Area

Medical Science Liaison on contract to Ipsen Biopharmaceuticals, supporting Somatuline® Depot (lanreotide) Injection.

Houston, Texas Area

Support Somatuline (lanreotide) Depot, a sustained release formulation of a somatostatin analog, across 17 states in the Central USKey opinion leader contacts include both academic and private cliniciansExperience and training in pituitary adenomas and neuroendocrine tumorsIdentified opportunities to sponsor both CME and Investigator-Initiated Studies

Houston, Texas Area

InGeneron is a small, early stage medical device company developing products to assist plastic and orthopedic surgeons. It has global reach with medical and veterinary clients worldwide. My responsibilities included the MSL role, building relationships with key opinion leaders and responding to queries from clinicians and sales reps in multiple indications for products at different stages of regulatory approval worldwide.Therapeutic Areas: • Inflammation • Orthopedics• Wound healing • Radiation exposure• Muscular dystrophy• Cosmetic and reconstructive applications of fat grafting

Houston, Texas Area

Created and presented a seminar on the use of tetracyclines to treat rosacea for the Medical Science Liaison department of a leading pharmaceutical company.

Scientist, communicator, manager, and inventor • Collaborated extensively with departments in several therapeutic areas • Negotiated and executed 100 material transfer agreements worldwide • Inventor on 23 issued US patents • Represented Lexicon at scientific meetings • Reduced costs by discovering and developing new methods • Increased revenues by finding new ways to commercialize our discoveries • Managed a scientific department of up to 16 people • Worked closely with our intellectual property group both as an inventor and in the course of negotiating material transfer agreements

• Awarded Alexander Hollaender Distinguished Postdoctoral Fellowship • Imported and developed microarray technology for the laboratory of Eddy Rubin, MD, PhD, one of the world leaders in mouse genetics • Worked closely with engineers on site, and collaborators at Stanford, to set up a new robot and laser system for the study of mouse biology • Imported a mouse model of schizophrenia for the study of behavioral genetics • Imported a mouse model of cardiac hypertrophy and identified novel genetic pathways • Generated novel transgenic mice to explore these findings

Ph.D.

B.A.

Education record